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AbstrAct
Voltage-Dependent Anion selective Channels (VDAC) are pore-forming 
mitochondrial outer membrane proteins. In mammals VDAC3, the least characterized 
isoform, presents a set of cysteines predicted to be exposed toward the intermembrane 
space. We find that cysteines in VDAC3 can stay in different oxidation states. This 
was preliminary observed when, in our experimental conditions, completely lacking 
any reducing agent, VDAC3 presented a pattern of slightly different electrophoretic 
mobilities. This observation holds true both for rat liver mitochondrial VDAC3 and for 
recombinant and refolded human VDAC3. Mass spectroscopy revealed that cysteines 
2 and 8 can form a disulfide bridge in native VDAC3. Single or combined site-directed 
mutagenesis of cysteines 2, 8 and 122 showed that the protein mobility in SDS-
PAGE is influenced by the presence of cysteine and by the redox status. In addition, 
cysteines 2, 8 and 122 are involved in the stability control of the pore as shown by 
electrophysiology, complementation assays and chemico-physical characterization. 
Furthermore, a positive correlation between the pore conductance of the mutants and 
their ability to complement the growth of porin-less yeast mutant cells was found. Our 
work provides evidence for a complex oxidation pattern of a mitochondrial protein 
not directly involved in electron transport. The most likely biological meaning of 
this behavior is to buffer the ROS load and keep track of the redox level in the inter-
membrane space, eventually signaling it through conformational changes.
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INtrODUctION
The voltage-dependent anion selective channels 
(VDAC) are a family of proteins whose primary role 
is to transport hydrophilic metabolites and molecules 
through the mitochondrial outer membrane (MOM). 
In mammals evolution yielded three distinct VDAC 
isoforms, but the specific biological function for the 
presence of three distinct genes is not clear yet [1]. Among 
them, VDAC1 is the best characterized isoform [2, 3, 4] 
which was shown to play an important role in several cell 
processes, including apoptosis [5, 6], calcium homeostasis 
[7], in diseases such as cancer [8] and in general it 
takes part in controlling the energetic metabolism [9]. 
Deficiency of VDAC1 has been associated with a lethal 
encephalomyopathy [10]. VDACs contain a common 
amphipathic trans-membrane β-barrel motif formed by 
19 β-strands and a short N-terminal sequence that has a 
partial character of α-helix. The N-terminal sequence 
exhibits differences between the three isoforms. In the 
available 3D structures of VDAC1 [11, 12, 13] and of 
VDAC2 [14], the N-terminal domain presents an α-helical 
folding among residues 6-20 and runs along the channel 
making contacts with the internal face of the pore. It 
has been proposed that the channel can be regulated 
by a gating mechanism involving the movement of the 
N-terminal domain [15]. VDAC3, although shares about 
60-70% sequence identity with VDAC1 and VDAC2, 
remains the least known isoform. Contrary to VDAC1 and 
VDAC2, VDAC3 is indeed unable to recover the growth 
defect of a yeast strain devoid of the endogenous VDAC 
(Δpor1) on non fermentable carbon sources at 37°C 
[16, 17]. VDAC isoform 3 was even considered unable 
to form channels in artificial membranes [18]. Recently, 
an electrophysiological activity, characterized by very 
low conductance levels, was described for recombinant 
human VDAC3 (hVDAC3) [19]. In a previous work 
[20], we demonstrated that the replacement of the first 20 
amino acids of the N-terminal region of hVDAC3 with 
the corresponding residues of hVDAC1 was sufficient to 
radically change the features of the protein. The swapping 
chimera hN1-VDAC3 restored the growth of Δpor1 yeast 
cell on glycerol at 37°C [20] and, upon reconstitution 
in planar bilayers, inserted easily into the membrane, 
showing a channel conductance comparable to VDAC1 
[21]. This result prompted us to analyze in detail the 
N-terminal sequence of VDAC3. Human VDAC3 has six 
cysteines (seven in rat), two of them in the N-terminal 
domain, while VDAC1 only has two (no one of them 
in the N-terminal). VDAC2 too has a large number of 
cysteines, nine in human and mouse, but only one of them 
is conserved in the N-terminal in position corresponding 
to VDAC3. Based on the recent determination of the 
transmembrane topology of VDAC [22], four of the six 
cysteines of hVDAC3 are predicted to be located in the 
connection loops between β-strands, protruding towards 
the intermembrane space (IMS) (Cys36, Cys65, Cys122, 
Cys229) and two are located in the N-terminal domain 
(Cys 2 and Cys8), with the more proximal of them also 
exposed to the IMS (Cys2). When a cysteine residue is 
exposed on the surface of a protein, it can interact with 
H-bond partners (e.g. water molecules). These interactions 
polarize the bond and induce a significant decrease of pKa. 
Exposed cysteines can thus easily shift from the reduced 
to the oxidized form in response to small fluctuations of 
the pH. In the IMS reactive oxygen species (ROS) are 
poured by the complex III [23] and by monoamine oxidase 
[24] and the pH is more acidic because of the pumping 
activity of the electron chain complexes [25]. It is 
therefore remarkable that in hVDAC3 most of the cysteine 
residues are exposed to the oxidative and slightly acidic 
environment of the IMS. The exposure of the hVDAC3 
cysteines suggests that they should be highly reactive and 
available to bear modifications of their oxidation state. 
In this work, we have investigated the redox state of 
cysteines both in a recombinant human VDAC3 protein 
and in rat mitochondrial VDAC3. We studied the results 
of cysteine removal in terms of the modification of the 
biological and biophysical features of the protein.
rEsULts
Reduction of VDAC3 cysteines modifies the 
protein electrophoretic pattern
A comparison between VDAC3 and VDAC1 
highlights the presence, in VDAC3, of a higher number 
of cysteines (Figure 1A). In Figure 1B a structural model 
of hVDAC3 (obtained from [26]) shows the localization 
of cysteines in the predicted structure. As mentioned 
above, four out of six cysteine residues (Cys36, Cys65, 
Cys122, Cys229) are located in loops connecting β-strands 
and are thus exposed to the intermembrane space (IMS). 
Moreover, even if the N-terminal tail is localized 
inside the pore, as found in the template structure [12], 
in the homology model Cys2 is oriented toward the 
intermembrane space [26]. The exposure of the hVDAC3 
cysteines suggests that they are highly accessible to 
soluble oxidative molecules and for this reason they are 
possibly linked to some specific biological function.
For a preliminary investigation of the redox state 
of VDAC3 cysteines, recombinant hVDAC1, hVDAC3 
and the chimera hN1-VDAC3 [20] were expressed, 
refolded and probed to be active in reconstitution 
experiments (see below), and then subjected in vitro to 
reducing or oxidizing conditions (Figure 1C). To avoid 
any potential interference in the light of our purposes, 
DTT or any reducing chemical was omitted throughout 
the whole procedure unless clearly described. For in vitro 
modifications, aliquots of the recombinant proteins were 
Oncotarget2251www.impactjournals.com/oncotarget
Oncotarget2252www.impactjournals.com/oncotarget
either incubated with the oxidizing agent diamide, or 
with the reducing DTT at 4 °C, acetone-precipitated and 
next ran in SDS-PAGE without reducing agents. While 
hVDAC1 showed the expected electrophoretic migration 
corresponding to the estimated Mr (35 kDa), in the various 
conditions, hVDAC3 was almost completely present in the 
top of the gel, most probably in an aggregated form, even 
though minor bands were visible at the expected Mr of 
the monomeric form and at intermediate migration levels. 
Oxidation by diamide did not relieve the aggregation, 
while reduction by DTT restored hVDAC3 migration 
at the expected molecular weight of 35 kDa, as a single 
homogeneous band (Figure 1C). The presence of double 
bands does not indicate truncated forms of the protein 
according to Mass Spectrometry (see below) and to the 
effect of reduction by DTT. VDAC3 has been shown to 
migrate faster than VDAC1 in reducing SDS-PAGE [27]. 
Instead, the presence of a faint band above the major one 
suggests that even the recombinant protein carries slight 
oxidation, possibly responsible for the band duplication. 
Other proteins have been shown to modify their 
electrophoretic mobility upon cysteine oxidation [28]. 
hN1-VDAC3, lacking the two cysteines in the N-terminus, 
in reducing conditions had the same mobility of VDAC1, 
and completely entered into the gel without the addition 
of DTT (Figure 1C). This result indicates that oxidized 
VDAC3 tends to oxidize easily and aggregate; the 
aggregation can be dissolved by a reducing agent. In this 
artificial system the main responsible for the aggregation 
of recombinant hVDAC3 appear to be C2 and C8. Similar 
results were obtained when the VDAC3 was in 8M urea, 
before the refolding procedure (not shown).
The removal of specific cysteines changes 
electrophoretic migration of hVDAC3
Suspecting a key role for the N-terminal cysteines 
in the electrophoretic mobility of hVDAC3, site-directed 
mutagenesis was used to substitute these amino acids with 
alanine residues. In particular we focused on cysteine 2, 
8 and 122, the latter two being the closest residues to C2 
on the basis of our predictions (Figure 1B). Single, double 
and triple mutant hVDAC3 sequences were cloned in 
Figure 1: Cysteine content influences VDAC3 features. A. VDAC3 has more cysteine residues than VDAC1. Recombinant 
human VDAC3 (RhVDAC3), rat VDAC3 (ratVDAC3), human VDAC1 (hVDAC1) were aligned with Clustal omega 1.2.1. In yellow are 
highlighted the cysteine residues. The numbered bars indicate predicted β-strands. RhVDAC3 (recombinant human VDAC3) shows also 
the poly-His tag. Notice that the cysteine residues in VDAC3 never are in β-strands, at a variance from VDAC1. B. A structural model of 
human VDAC3 showing the localization of cysteine residues, represented in orange-licorice and with the sulfur atoms as yellow balls. 
The homology model of hVDAC3 was obtained from the template X-ray structure of mouseVDAC1 (PDB:3EMN). The model was built 
using MODELLER 9v5 and the image by means of the program VMD 1.9.2. Assuming the sidedness reported in [22], cysteine residues 
in VDAC3 protrude toward the intermembrane space. C. Cysteine content changes protein electrophoretic mobility. hVDAC1, hVDAC3 
and hN1-VDAC3 were pre-incubated with 1 mM diamide or 50 mM DTT and loaded on a 12% Nu-Page Novex gel without any reducing 
agent. A not-treated sample was used as control. 1X MES buffer was used for the run. hVDAC1 shows the expected electrophoretic 
migration. hVDAC3 is almost completely aggregated unless it is reduced with DTT. hN1-VDAC3 behaves similarly to hVDAC1 and does 
not aggregate at all. 
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pET21a vector, for protein expression in E. coli. Following 
purification, recombinant hVDAC3 mutants were refolded 
using an established protocol demonstrated to form 
active pores, and run in SDS-PAGE in the presence or 
absence of reducing agents (Figure 2A-2B). Any mutant 
protein, reduced with DTT, had the same electrophoretic 
mobility (Figure 2A). Conversely, without the reducing 
agent, each protein showed peculiar migration(s) in the 
gel (Figure 2B). The two VDAC3 single mutants C2A 
and C8A showed the same electrophoretic pattern of 
hVDAC3 wild type, indicating that the ablation of each 
of these cysteines, alone, does not change the proteins’ 
electrophoretic mobility. In the same conditions, the 
single mutation C122A showed a complex pattern with 
several bands at various apparent Mr and, among them, 
a band clearly corresponding to a possible dimer. The 
deletion of two (C2,8A, C2,122A, C8,122A) or three 
cysteines (C2,8,122A) essentially reestablished a more 
homogenous electrophoretic migration, decreasing the 
protein aggregation. These data were confirmed in other 
gels where each mutant protein was overloaded and 
subjected to an oxidizing treatment with diamide (Suppl. 
Figure 1).
The cysteine residues affect hVDAC3 activity in 
Δpor1 yeast cells
As already mentioned, unlike VDAC1 and VDAC2, 
VDAC3 is not able to allow Δpor1 yeast cells to grow 
on non fermentable carbon sources like glycerol at 
37°C [16]. Therefore, to evaluate the effects of the 
mutagenesis of cysteine residues on protein activity in 
vivo, hVDAC3 cysteine mutants were cloned in pYX212 
vector for protein expression in S. cerevisiae, and used 
in complementation assays together with hVDAC1, 
hVDAC3 and hN1-VDAC3 as controls (Figure 3A). 
While no particular difference was observed on glucose 
at 28°C, most of hVDAC3 mutants improved Δpor1 cell 
growth on glucose at 37°C and glycerol at 28°C compared 
to the control. Conversely, only Δpor1 cells transformed 
with hVDAC3 double mutants C2,8A and C2,122A and 
the triple mutant C2,8,122A were able to grow on glycerol 
at 37°C, the most restrictive condition. A partial recovery 
was also observed with C2A. Interestingly, hVDAC3 
C8,122A did not show the same behavior as the other two 
double mutants, suggesting a particular relevance of C2 
in channel activity. Its removal indeed, together with C8 
Figure 2: Selective cysteine mutations change the electrophoretic behavior and the ability to complement a porin-
defective yeast strain. A. Reduced hVDAC3 mutants show the same electrophoretic mobility. Recombinant refolded hVDAC3 Cys-- > 
Ala mutants were reduced with 50 mM DTT and run on a 12% NuPAGE Novex. M: Molecular weight markers: the migration of 66 and 30 
kDa marker proteins is shown. The arrow indicates the VDAC3 mobility. B. Not reduced hVDAC3 mutants show different electrophoretic 
mobilities. The protein samples showed in A were run in a 12% Nu-Page Novex gel in non-reducing conditions and without any prior 
reducing incubation. 
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and/or C122, not only allowed hVDAC3 to complement 
Δpor1 growth defect, but also strongly lowered the amount 
of aggregated protein in non-reducing conditions (Suppl. 
Figure 1).
The effect of pro-apoptotic agents on ∆por1 
cells transformed with the various mutants was also 
investigated. As already reported [29], acetic acid 
triggers apoptosis in yeast through mitochondrial ROS 
accumulation and decrease in mitochondrial respiration. 
The lack of endogenous VDAC1 in yeast makes the cells 
much more sensitive to acetic acid than the wild type ones 
[30]. Whereas the transformation with hVDAC1 and hN1-
VDAC3 increased the resistance of ∆por1 strain to 60 mM 
acetic acid, hVDAC3 failed to do the same. The analysis 
of hVDAC3 mutants growth on acetic acid is shown in 
Figure 3B. It is interesting to note that the removal of 
a single cysteine of the N-terminal domain (hVDAC3 
mutants C2A and C8A) allows Δpor1 yeast cell to grow 
on medium containing acetic acid, while the simultaneous 
removal of both residues does not determine the same 
effect. This is in contrast with the results obtained for the 
chimera hN1-VDAC3, which increases the resistance of 
Δpor1 strain to acetic acid although without cysteine 2 
and 8. One possible explanation is that the amino acids 
around the hVDAC1 N-terminus, being different from that 
of hVDAC3, could influence the effect of oxidative stress 
on these residues. The absence of the cysteine 122 alone or 
together with the cysteine 2 is not sufficient to change the 
behavior of hVDAC3 towards acetic acid. On the contrary, 
the removal of the cysteine 122 together with the residue 8 
or the simultaneous absence of all three cysteine residues 
(hVDAC3 mutant C2,8,122A) allows Δpor1 yeast cells 
to grow on 60 mM acetic acid. These data highlight that 
the different cysteines probably play distinct roles in the 
response to mitochondrial ROS.
The cysteine residues oxidation influences the 
electrophysiological features of VDAC3
The human VDAC3 Cys mutants expressed in vitro 
were refolded and studied in a planar bilayer set-up to 
detect their ability to form conductive pores in the artificial 
membrane. We previously reported a characterization of 
recombinant hVDAC3 where we detected ion channels 
with a substantially lower conductance than VDAC1 [19]. 
Data reported in the present paper (Figures 1C and 2A) 
suggest that the preparation we used for our study with 
recombinant hVDAC3 is actually a mixture of proteins 
each displaying a different cysteine redox state. The lack 
of redox homogeneity in the protein sample might be the 
cause of the poor incorporation of the protein in artificial 
membrane or of the various pore-conductance states [18-
19].
We thus performed a careful analysis of the action of 
reducing agents on the pore-forming activity of VDAC3. 
The recombinant hVDAC3 we used was isolated under 
non-reducing conditions. However, since the -SH groups 
of the cysteine might be oxidized at various extent 
as shown in this work and this may have an impact on 
the single channel conductance, we performed bilayer 
experiments with VDAC3 pre-incubated with reducing 
Figure 3: A. hVDAC3 cysteine mutants have different behaviors in Δpor1 yeast complementation assay. Δpor1 yeast transformed with 
hVDAC3 containing different set of Cys-to-Ala mutations were tested in a drop-serial dilution assay. hVDAC1, hN1-VDAC3 and hVDAC3 
were used as controls. Cells were plated on media containing glucose or glycerol as the sole carbon source and incubated at 28°C and 37°C 
for 4-5 days. Only C2,8A, C2,122A and C2,8,122A mutants enable Δpor1 to grow on glycerol at 37°C. A partial recovery is also observed 
with C2A mutant. B. hVDAC3 mutants react differently to the pro-apoptotic stimulus of acetic acid. In the presence of 60 mM acetic acid, 
only hVDAC3 C2A, C8A, C8,122A, and C2,8,122A allowed the yeast growth. The figure shows a representative panel of experiments. 
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agents (DTT and β-mercaptoethanol) or treated with 
these agents during the experiment at pH 7.0 (n = 8) 
(Suppl. Figure 2A-2B). In 41 independent experiments 
carried out at pH 7.0 with VDAC3 in 1 M KCl without 
addition of reducing agents, we observed activity with 
well-resolved openings and closures (gating) and with a 
single channel conductance ranging between 90 and 140 
pS, in accordance with our previous results [19]. In rare 
cases, conductance values larger than the unitary one 
were observed, and, most probably, this was due to the 
cooperative gating illustrated in Suppl. Figure 2D (see 
also respective histogram where numerous distinct current 
levels co-exist throughout the experiment). Finally, in 4 
experiments out of these 41, single 3 nS steps have been 
observed more than half an hour after the incorporation 
of the small-conductance form, and only if the membrane 
was kept at ±10 mV potential for the whole experiment. 
However, when already the purification and refolding has 
been carried out in the presence of DTT, the situation was 
different: in three bilayer experiments where DTT was 
included also in the experimental medium, we detected 
events with high conductance levels typical of VDAC1 
(Suppl. Figure 2E) (for reviews see [31, 32]), also in 
accordance with the findings of Okazaki [33]. Please note 
however, that the redox state of the IMS renders unlikely 
operation of VDAC3 in a fully reduced state in vivo.
Next, the hVDAC3 cysteine mutants’ pore-forming 
activity was characterized at the bilayer set-up (number 
of experiments ranging from 4 to 16), revealing that at 
pH 7.0 (without addition of reducing agents), different 
Cys residues have distinct roles in the stabilization of the 
high-conducting state of VDAC3. Table I summarizes the 
conductance values recorded with the various mutants 
as well as their ability to complement the growth of the 
yeast mutants. Figure 4 shows the representative single 
channel behavior of wtVDAC3 and of individual Cys- > 
Ala mutants. C2A mutation increased the single channel 
conductance, with values ranging from 750 to 900 pS in 
the various experiments, as determined from the respective 
amplitude histograms (not shown) (n = 4 independent 
experiments) (Figure 4B). Furthermore, the channel was 
operating mostly in the open state and displayed brief 
closures. C8A mutation, instead, reproducibly resulted in 
a small-conductance activity with g values ranging from 
70 to 100 pS (n = 4 independent experiments) (Figure 4C) 
i.e. similar to those of wt hVDAC3. In addition, channel 
activity was characterized by fast closures and openings 
(flickering), indicating that this mutation affects the kinetic 
behavior of VDAC3. C122A mutant, similarly to C8A, did 
not induced conductance or voltage-dependence or kinetic 
behavior changes with respect to VDAC3 [19]. Indeed, 
the channel was active also at high potentials (Figure 4D). 
In the double mutant C8,122A, VDAC3 tended to adopt 
a higher conductance state (ranging between 350 and 400 
pS, n = 8) and slow kinetics (Figure 4E), suggesting that 
these two residues might contribute to keep the pore in 
a relatively low conductance state. Please note that the 
individual mutation of C8 and C122 did not strongly alter 
the characteristics of the wt channel instead. The C2,8A 
double mutant had a significantly higher single channel 
conductance than wt, with an average value of 1.3-1.4 
nS (n = 16). Figure 4F illustrates the typical behavior of 
this double mutant: with an applied voltage up to +/-60 
mV the channel operated in a completely open state. The 
simultaneous opening of several channels in the same 
membrane yielded whole-membrane conductance levels 
ranging up to 10 nS. 
At higher potentials, where the channels start to 
close, it is well visible that closures took place in distinct 
steps of events with a conductance of 1.3 nS. The C2,122A 
mutant also displayed a high conductance (between 850 
and 900 pS in the various experiments, n = 4) and fast 
gating, in a reproducible way (Figure 4G). Thus, the 
experiments with double mutants indicated that these three 
cysteine residues are subject to oxidation(s) affecting the 
channel behavior. Finally, we investigated the properties 
of the triple C2,8,122A mutant (Figure 4H-4K). In the 
case of the triple mutant, we repeatedly observed that 
the pore adopted lower conductance states (around 200 
pS) mainly at low membrane potentials, but also a higher 
conductance state with a g value around 1 nS (Figure 4I). 
The pore again tends to close at potentials higher than 
±80 mV. Thus, either single or multiple mutations of the 
VDAC3 selected cysteine recapitulate the VDAC1 typical 
high-conductance state, although the voltage-dependence 
remains different (VDAC1 starts to show closing events at 
applied voltages of 30-40 mV).
Mass spectrometry demonstrates that VDAC3 
cysteines exist in different oxidation states
The oxidation state of hVDAC3 cysteines was 
thoroughly investigated by mass spectrometry. The 
analysis was performed both on recombinant, refolded 
hVDAC3 and on VDAC3 purified from rat liver 
mitochondria. Recombinant hVDAC3 was overloaded 
on SDS-PAGE gels without any treatment (Figure 5A) or 
following reduction with DTT (Figure 5B). Stained bands 
were cut out and treated as described in Methods. A set 
of gel bands was not subjected to the reducing/blocking 
treatment prior to the addition of proteolytic enzymes in 
order to detect the cysteine(s) oxidized state(s) (including 
the putative presence of disulfide bridges). Another set 
of gel slices was reduced by DTT and alkylated with 
iodoacetamide to avoid further modifications during the 
detection procedure. The resulting peptides were detected 
by an Orbitrap Fusion™ Tribrid™ mass spectrometer 
and analyzed. The state of the cysteines that we were 
able to detect is summarized alongside the gel (Figure 
5A-5B). Analysis of the untreated sample led to the 
identification of a disulfide bridge between the cysteine 
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2 and 8 in the N-terminal domain (Suppl. Figure 3A). 
The S-S bridge was present not only in the aggregated 
form of the protein (band 1A in Figure 5A) but also in 
the monomeric form (band 5A in Figure 5A). C2 and 
C8, together with C36, C65, and C229 were found also 
in different oxidation states: sulfonic, sulfinic and -SH 
reduced form. However, in hVDAC3 treated with DTT 
(Figure 5B), most of the protein was in the monomeric 
form, and the trace amounts found in the bands 1C-5C 
did not permit a reliable detection. In the band 6C, every 
cysteine was found in the reduced form, comprising 
C122 that was detected thanks to an alternative cleavage 
with chymotrypsin. Nevertheless, most of the cysteines 
were also found in the sulfonic acid state, an irreversible 
oxidation state that cannot be reduced by DTT treatment. 
Cysteines were then analyzed in VDAC3 prepared directly 
from mitochondrial extracts. Rat liver mitochondria were 
solubilized with Triton X-100 and chromatographed 
through a hydroxyapatite (HTP) column [34]. Since there 
is no established protocol for the purification of VDAC3 
from tissues, the protein is enriched in the HTP eluate [35] 
that contains several electrophoretic bands in the range 
of 30-35 kDa [35]. The HTP eluate was either reduced 
or oxidized and run on a gel. Stained bands were cut out 
and treated for mass spectrometry analysis as reported 
above. It must be taken into account that rat VDAC3 has a 
seventh cysteine (Cys165), in addition to the six in human 
(Figure 1A). Figure 5C shows that in the untreated sample, 
VDAC3 was found in different gel bands in the 30-35 
kDa area, most likely due to the different redox states of 
cysteines. Also in the mitochondria derived protein, the 
absence of a reducing treatment of the sample allowed the 
identification of a disulfide bridge between cysteine 2 and 
8. Cysteine 36 was detected in all possible oxidative states 
(reduced, sulfonic and sulfinic), while C65 and C165 were 
found in both reduced and sulfonic states. Coverage of 
C229 was not obtained. In the reduced sample (Figure 
5D), the disulfide bridge was obviously absent and 
cysteines 2, 8 and 36 were found only in the reduced form. 
C65 and C165 were found reduced, but also irreversibly 
oxidized and C229 was detected only in the sulfonic form 
(band 1C and 6C Figure 5D). The peptide containing 
Cys122 was never detected, possibly because part of a 
large tryptic peptide. Interestingly, the stained band at 
high molecular weight in SDS-PAGE (Figure 5D, band 
1C) contains evidence of rat VDAC3 peptides: this means 
that VDAC3 can also aggregate in mitochondria. VDAC1 
has earlier been shown to be able to form homomultimers/
aggregates under certain conditions (e.g. [36]).
Molecular dynamics analysis of cysteines 2-8 
disulfide bridge in VDAC3
A disulfide bridge can form in mitochondrial 
VDAC3. Suppl. Figure 3A-3B shows the spectra of 
representative tryptic peptides containing the disulfide 
bridge C2-8 both in the recombinant hVDAC3 and in the 
mitochondrial rat VDAC3. The VDAC3 disulfide bridge 
C2-8 was simulated by molecular dynamics (MD), to 
investigate the functional consequences of the bond. The 
structural features of the disulfide-bonded variant of the 
VDAC3 channel are illustrated in Figure 6, where the 
last frame of the fifth 100 ns production run is shown. A 
feature of the VDAC channel is that both the N-terminal 
and C-terminal point towards the same direction (positive 
z-axis in our simulations). In VDAC3 containing the 
disulfide bridge C2-8, the disulfide bends the N-tail 
over itself so that fragment 1-12 now runs downwards 
roughly parallel to segment 13-25 that is still directed 
upwards. In the MD simulation, the bend induced by the 
covalent disulfide bond causes the whole N-terminal to 
Figure 4: Conductance and voltage-dependence of hVDAC3 single, double and triple Cys>Ala mutants. A.-D. 
Representative current traces recorded for (A): WT hVDAC3; (B): C2A; (C): C8A; (D): C122A. The mutants activities were recorded 
at varying applied potentials (left panels) and in an expanded time scale at the indicated voltages at pH 7.0 in 1 M KCl (right panels). 
The voltage protocol applied (left panels) allowed us to record channel activity at steady-state voltage and to better visualize the kinetic 
behavior of the channel (right panels). Tendency to close at higher voltages than ±30 mV was never observed, indicating that the voltage-
dependence of wt VDAC3 was maintained ((A) and see also [19]). Open and closed states are indicated with “o” and “c”, respectively. 
In (A) conductance is 90 pS. In (B) activity recorded for C2A reveals a conductance of 800 pS and long-lasting open states (o). In (C) 
a conductance of 100 pS was observed for C8A, while in (D) activity recorded at Vcis of +40 mV with a conductance of 90 pS can be 
observed for C122A. E.-G. Traces for the indicated double mutants reported as in (A-D). The observed conductances for the examples 
shown are as follows: (E): C8,122A: 400 pS (for open level o2, Vcis +40 mV); (F): C2,8A: 1,2 nS (at Vcis +40 mV); (G): C2,122A: 
800 pS (Vcis +40 mV). In (E) also a smaller conductance level (o1) can be observed. Both C2,8A and C2,122A mutants tend to close at 
potentials higher than ±30 mV, suggesting that modification of cysteine residue 2 may be an important element of VDAC3 channel activity 
modulation. Similar activities have been observed in at least 4 different experiments for each mutant. H. Upper current traces showing 
representative activity from an experiment with the triple mutant hVDAC3 C2,8,122A recorded in 1 M KCl at pH 7.0 in non-reducing 
conditions at the indicated voltages. I. As in H from the same experiment. A clear tendency to close at voltages higher than ±60 mV has been 
observed in other 5 experiments. In the presented experiment, the channel was operating in the low-conductance state at lower potentials, 
while at + 40 mV simultaneous opening of more channels was observable. J. At -60 mV and at + 60 mV an overall conductance of 4.6 nS 
was measured, as shown also in the amplitude histogram, but single channel activities with 1 nS conductance are well resolvable both in 
the current trace and in the histogram. K. A representative current trace from another experiment with a conductance of 1 nS. Similar data 
were obtained in 6 experiments.
Oncotarget2259www.impactjournals.com/oncotarget
Oncotarget2260www.impactjournals.com/oncotarget
Figure 5: Mass spectrometry analysis reveals the presence of different redox patterns of VDAC3 cysteines in 
electrophoretic distinguishable protein bands. Recombinant refolded hVDAC3 or rat liver mitochondria HTP pass-through were 
overloaded on 17.5% SDS-PAGE. Each separated band was cut out of the gel and the content was subject to Mass Spectrometry. The 
redox state of the tryptic peptides present in each band was detected and annotated in the corresponding Table. A. Non-treated recombinant 
hVDAC3 was loaded on a 12% SDS-PAGE and run without any reducing agent. Coomassie blue stained polypeptides were identified as 
band 1A to 5A. MW: standard Mr markers (Sigma). B. Recombinant hVDAC3 was reduced with 50 mM DTT and loaded on a 12% SDS-
PAGE. Coomassie blue stained polypeptides were identified as bands 1C to 6C. (*) indicates that C122 was only found upon chymotrypsin 
digestion. C. Non-treated HTP eluate form rat liver mitochondria was loaded on SDS-PAGE and run without any reducing agent. Coomassie 
blue stained polypeptides were identified as band 1A to 6A. D. HTP eluate form rat liver mitochondria was reduced with 50 mM DTT and 
loaded on SDS-PAGE. Coomassie blue stained polypeptides were identified as band 1C to 8C.
Table 1: Correlation between conductance values and complementation in yeast
Protein Yeast complementation 
Most frequently 
observed conductance 
states Voltage dependence
hVDAC1 YES 3000 pS(n=6)
Voltage-dependet, tendency to close at 
applied voltages >30 mV
hVDAC3 NO 90 pS(n=4)
No Voltage-dependence, no closure even at 
high applied potentials
N1-hVDAC3 YES 1000 pS(n=12)
Tendency to close only at high applied 
voltages
hVDAC3 C2A PARTIAL 750-900 pS(n = 4)
Tendency to close only at high applied 
voltages (V>60 mV)
hVDAC3 C8A NO 70-100 pS(n = 4) No Voltage-dependence
hVDAC3 C122A NO 150 pS(n = 6) No Voltage-dependence
hVDAC3 C2-8A YES 1200-1400 pS(n = 16)
Tendency to close only at high applied 
voltages (V>60 mV)
hVDAC3 C2-122A YES 800-900 pS(n = 4) No Voltage-dependence 
hVDAC3 C8-122A NO 350-400 pS(n = 8) No Voltage-dependence
hVDAC3 C2-8-122A YES 1100 pS(n = 11)
Tendency to close only at high applied 
voltages (≥80 mV)
Voltage dependence is also reported. Values are based on at least 4 independent experiments for each mutant. Abbreviations 
used as in the text.
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stay closely packed to the wall of the barrel (strands 3-9). 
The N-tail bending results in a certain level of obstruction 
of the channel. This can be better appreciated in Figure 
6B, where a top view is shown. The steric hindrance of 
the VDAC3 channel in the disulfide bonded species was 
quantified through a calculation of the solvent accessible 
surface area (ASA). From the profile of ASA (Suppl. 
Figure 4), a decrease occurs in the lower region of the 
pore in the case of VDAC3 containing the disulfide bridge 
2-8. It can be noted that the drop in the accessible surface 
caused by the formation of the disulfide bridge 2-8 is small 
(about 12%). Assuming that this model is coherent with 
the physiological state of the pore, the ion current in the 
S-S bridged VDAC3 should be only slightly lower with 
respect to the form with the same cysteines in reduced 
state. Concerning the possible pathways for cations and 
anions, we based on a previous work [25] where we found 
two possible paths for chloride ions, one close to the 
N-terminal helix, the second one near the barrel and, on 
the other hand, only one path for potassium. The presence 
of the C2-8 disulfide bond should strongly perturbate the 
chloride path close to the N-terminal domain. Chlorides, 
however, can still cross the channel through the alternative 
path.
Chemico-physical measurements reveal that 
cysteine 8 stabilizes hVDAC3
Commensurate with its predicted structure, 
hVDAC3 exhibits a characteristic far-UV circular 
dichroism (CD) profile of a β-barrel protein (Suppl. 
Figure 5). The mutation of cysteine residues does not 
largely affect the overall structure of the protein (Suppl. 
Figure 5). Therefore, we examined the stability of 
hVDAC3 to unfold by heat, by monitoring changes in 
secondary structure using reported CD methods [37]. 
When we denatured transmembrane β-barrels such as 
VDAC by heating, protein unfolding was irreversible. 
Such irreversible nature is a biophysical characteristic 
common for proteins that are under kinetic control [38]. 
Heating weakens protein interaction with its surrounding 
lipid environment, and causes the protein to unfold. 
Once unfolded, aggregation ensues immediately - this 
process buries hydrophobic segments of the protein from 
the aqueous environment. Such non-specific protein 
aggregation differs from the oligomerization of VDACs, 
by the nature of the pathway. The folded VDAC mediates 
protein oligomerization in the membrane in a controlled 
and reversible manner [39]. However, irreversible 
aggregation that we obtained in our thermal denaturation 
measurements is non-specific, is nucleated by the unfolded 
protein, occurs outside the membrane and is irreversible 
[40]. In our experiments, hVDAC3 and its cysteine 
mutants exhibited irreversible thermal denaturation, with 
coupled unfolding and aggregation events. In 1% LDAO, 
the unfolding is cooperative for all the proteins, with 
the folded and aggregated states linked by a two-state 
process (Figure 7). A closer examination of the unfolding 
data reveals that in hVDAC3-C8A, the pre-transition 
baseline suggests that the protein undergoes a marginal 
loss in secondary structure by ~20%, before the onset of 
the two-state transition. This indicates that C8 may play 
an important role in hVDAC3 stabilization. We derived 
the thermal unfolding parameters Tm-start, Tm and Tm-end for 
all the proteins. This is summarized in Suppl. Figure 6. 
The overall behavior of the C2A mutant was similar to 
that of native VDAC3, indicating that this cysteine may 
be dispensable for the stability of the barrel. However, 
upon the mutation of C8, in hVDAC3 C8A, we observed 
a reduction in the Tm by ~4 °C. This is further manifested 
in the lowered Tm-start by ~10 °C, resulting in a considerable 
difference in ΔTm. This data suggests that C8 plays a key 
role in structuring hVDAC3. Indeed, a close examination 
of the far-UV CD profiles reveals that the secondary 
structure content was marginally lowered for C8A (Suppl. 
Figure 5). The C2,8A mutant is further destabilized, when 
compared with hVDAC3 C8A. We, therefore, surmise 
that the cysteine residues present at the N-terminal helix 
of hVDAC3 are important to stabilize the barrel. Thus, 
their oxidation to form a disulfide bridge is destabilizing 
and possibly contributes to a conformational change of the 
protein.
DIscUssION
Cell requires perfectly functioning mitochondria. 
Nevertheless, the organelle is the source of redox species. 
The accumulation in mitochondria of oxidative agents can 
damage the organelle and cause in turn problems to the 
whole cell. An out-of-control ROS load in mitochondria 
must be signaled to the cell and an organelle heavily 
loaded with ROS must be evidenced and destroyed, 
if ineffective. The front-runner for this function is the 
mitochondrial outer membrane, as the border of the 
organelle towards the rest of the cell. VDACs are the most 
abundant protein spanning the MOM and thus connecting 
the IMS to the cytosol. The mitochondrial intermembrane 
space (IMS) has physicochemical properties distinct from 
the matrix and the two membranes: the pH is more acidic 
than cytosol by 0.2-0.7 units [25, 41] and the glutathione 
redox buffer is more oxidizing than in cytosol and in the 
matrix [42]. This composition produces an oxidizing 
environment that, in the cell, is exceeded only by the ER 
lumen. In addition, IMS is characterized by the abundance 
of ROS poured here mainly by Complex III [43, 44] but 
also by Complex II [45] and by the activity of MAO 
[24]. A delicate equilibrium, involving the presence of 
detoxifying enzymes like SOD1, permits the maintenance 
of “redox homeostasis”. ROS released from the IMS serve 
as signaling molecules to induce gene expression in the 
nucleus [46]. Among ROS, O
2
- superoxide is very active 
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although has a short life, while hydrogen peroxide (H2O2) 
is a permeable signaling agent able to oxidize cysteines to 
disulfides [47]. 
We have previously proposed the transmembrane 
topology of VDAC1 [22]. Based on this model, it has 
been predicted that four out of six cysteines of hVDAC3 
are exposed toward the IMS and the remaining two are in 
N-terminal moiety. In this scenario the VDAC3 cysteines 
are likely candidates to oxidation by ROS in the IMS. We 
found indeed that cysteines in VDAC3 can bear various 
oxidation states and a disulfide bridge between cysteine 
2 and 8 was also proven. Evidence for “overoxidation” 
of thiols, meaning the irreversible oxidation of a cysteine 
thiol to sulfinic or sulfonic acid [48] was reported in other 
works [44]. 
A very recent work, basically simultaneous to the 
present one, has proposed that cysteine oxidation and the 
formation of a disulfide bridge influence VDAC3 channel 
Figure 6: Molecular Dynamics model of VDAC3 containing the disulfide bond 2-8. A. typical structure of the wild type 
VDAC3 pore and B. of the disulfide bonded variant Cys 2-8 (SS 2-8). The N-terminal tail corresponding to fragment 1-25 is shown in 
magenta. The cysteine residues are shown in a ball-and stick representation. C. top view of the wild type VDAC3 channel and D. of 
the disulfide bonded variant Cys 2-8 (SS 2-8). The N-terminal tail corresponding to fragment 1-25 is shown in magenta with a surface 
filling representation that highlights the different degree of obstruction of the channel. The cysteine residues are shown in a ball-and stick 
representation.
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gating [33]. In their paper Okazaki et al reported the effect 
of recombinant VDAC3 reduction by DTT and studied 
some Cys to Ala mutagenized VDAC3. Both groups came 
to the same conclusion, i.e. that cysteines are relevant for 
the pore-function. Okazaki and colleagues hypothesized 
that the formation of the disulfide bridge between residues 
2 and 122 can influence the gating of the pore, favouring 
the closed state [33]. Our mass spectrometry analysis 
determined, instead, that a disulfide bridge is formed 
between Cys 2 and Cys8 but not between Cys 2 and 
Cys 122. Since the former disulfide bridge affects the 
N-terminal region, its relevance for the conductance of the 
pore appears to be limited, as shown by MD. On the other 
hand, the partial hindrance of the pore may have influence 
on the interaction with tubulin, a physiological inhibitor 
of the pore that plugs into its cavity [49]. It cannot be 
excluded that other disulfide bridges can form between 
other cysteines pairs: these events must not be based only 
on physical proximity but likely depend on other chemico-
physical properties of the surrounding structure as well. 
Unfortunately, experimental evidence to support this latter 
hypothesis is still missing. A relevant difference between 
our analysis and the work by Okazaki et al [33] is the 
observation reported here that VDAC3 cysteines may be 
found in several and variable oxidation states in addition to 
the disulfide bridge: this feature made the whole analysis 
of the protein function more complicated than expected 
but, importantly, it underlines a so-far unknown feature 
of VDACs which occurs also in vivo, as found in rat liver 
mitochondria. 
As a counter-proof of the importance of redox 
states of VDAC3 cysteines, the removal of selected 
cysteines reduces the dynamic range of oxidation states 
and had a clear impact on the function. These conclusions 
are based on the clear demonstration of changes in the 
electrophoretic pattern of cysteine mutants compared 
to hVDAC3, as discussed also in [33]. Even more 
interesting is the effect of such deletions on VDAC3 
gating. The electrophysiological data reported here show 
that deletion of C2 alone or together with C8 and/or C122 
Figure 7: Thermal denaturation studies of hVDAC3. A. Change in secondary structure content with increase in temperature 
plotted as fraction unfolded (fu) and fitted to a two state model (solid lines). The unfolding profiles for hVDAC3 WT (red circle), C2A (blue 
square), C8A (green triangle) and C2,8A (olive diamond) mutants are shown in the different panels. The error bars are generated from an 
average of 3-4 independent measurements. Black line directed to the y-intercept in the C8A panel highlights the drifting baseline, which 
indicates a marginal loss in the secondary structure content by ~20%, before onset of the actual unfolding. B. Thermal parameters (Tm, 
Tm-start, Tm-end and ΔTm) were calculated (see Suppl Fig. 5 for the calculation) from fu plots, and the contribution of cysteine residues to the 
protein stability was compared. The first set of bars show the comparative view of thermal midpoint (Tm) values, indicating higher stability 
of the WT and C2A, with respect to the cysteine mutants C8A and C2,8A. The T
m-start
 values corresponding to the initiation of unfolding 
also show that C8A and C2,8A unfold at lower temperatures, compared to WT and C2A. Similarly, the Tm-end value is highest for WT and 
C2A, again inferring that end point is reached at higher temperatures for these mutants. The difference between Tm-end and Tm-start (ΔTm) 
reflects the cooperativity of the unfolding process. WT and C2A show lower ΔTm values, suggesting that unfolding is highly cooperative in 
these mutants and is least cooperative for the double mutant C2,8A. Each data set represents an average of 3-4 independent experiments. A 
similar colour scheme is retained across all the panels.
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enable VDAC3 to insert more easily into an artificial 
membrane and to adopt a higher conductance state than 
the wtVDAC3. This result is in accord with the recent 
finding that the deletion of the Cys2 and 8 together, or 
the Cys 122 alone, changed the gating features and the 
voltage dependence of VDAC3 leading to a behavior 
resembling the characteristics of the other isoforms [33]. 
These three residues can indeed be considered the most 
relevant ones for the control of gating and determination 
of conductance of the VDAC3 pore. Importantly we have 
demonstrated here that there is a correlation between the 
gating properties of the recombinant VDAC3 mutants and 
their ability to complement the yeast growth in ∆porin1 
cell, since the mutants where Cys8 was mutagenized in 
alanine (C8A, C2,8A (partially), C2,122A and C2,8,122A) 
in general showed an higher activity than the wtVDAC3 
when the cells grew on non fermentable carbon source.
Furthermore, C2 and C8 may be involved in VDAC 
oligomerization upon extrusion of the N-terminal domain, 
as evidenced by the fact that the simultaneous absence 
of both residues or of one of them along with C122 
abolishes aggregation in vitro. Previous works suggested 
that VDAC1 N-terminal domain can be exposed, or at 
least be very accessible, from outside the pore, and can 
stimulate the formation of VDAC super-assemblies 
[50, 51, 21]. When a cysteine was introduced in the 
VDAC1 N-terminal sequence and the α-helix motif was 
destroyed by the introduction of proline, evidence of 
VDAC1 oligomerization through intermolecular disulfide 
formation was presented [51]. 
Interestingly, human VDAC2 also possesses higher 
cysteine content than hVDAC3 [37]. Functionally, 
however, VDAC2 can show larger conductance and 
different gating characteristics with respect to VDAC3 
[18]. Recent electrophysiology measurements show that 
the deletion of all nine cysteines of VDAC2 has a marginal 
effect on channel function in vitro [40]. Furthermore 
hVDAC2 and hVDAC3 share four common cysteines (2, 
36, 65 and 122; numbering based on hVDAC3), of which 
we observe athat C2 and C122 are important in VDAC3.
Evidence of VDAC3 as a preferred target of 
mitochondrial ROS generated by the complex III has 
recently come from a redox DIGE (two-dimensional 
fluorescence difference gel electrophoresis) proteomic 
study performed on intact and highly coupled rat heart 
mitochondria [44]. This method is based on differential 
thiol labeling with fluorescent CyDye maleimides and 
detects reversible oxidations of protein thiols. The authors 
convincingly showed that proteins of the intermembrane 
space, such as the mitochondrial import inner membrane 
translocase subunit TIM50, or the outer membrane protein 
VDAC3 were heavily targeted by complex III-derived 
ROS. VDAC3 featured a strikingly high increase in thiol 
oxidation by ROS. It is very relevant to our discussion 
that only VDAC3 was found oxidized but not VDAC2, 
despite the high number of cysteines in the latter protein. 
The authors concluded that “the pronounced selectivity 
by which some proteins were oxidized qualifies them 
as highly useful potential biomarkers to monitor the 
generation of mitochondrial ROS at specific sites and 
under defined conditions”, an implicit consideration about 
a relevant role of VDAC3 as redox sensor [44].
The question arises what is the function of 
VDAC3 cysteine oxidations in a cellular context? 
Besides establishing the protein fold, the functional 
meaning of disulfides is not known. Mitochondrial inner 
membrane (MIM) proteins like subunits of Complex I, 
the Rieske protein in complex III, subunits of the TIM 
translocases, and members of the mitochondrial carrier 
family [52] contain conserved cysteines facing the IMS. 
The oxidation of VDAC3 cysteines as described in this 
work could be the result of a balance between cysteine 
oxidation and reduction reactions taking place in the 
IMS. VDAC3 oxidations could also be used to keep 
track of the redox level in the IMS. Cysteine oxidation 
can be counterbalanced by the redox restoring systems 
like thioredoxins or glutathione. Nevertheless, the 
oxidation to sulfonic acid is irreversible and leads to a 
permanently modified (damaged) protein that can undergo 
conformational changes or degradation. Interestingly, 
in a proteomic survey of VDAC3-interacting proteins 
[53], there were found proteins able to act as transport 
proteins as serpin-6 or Ter-ATPase (VCP) (that transfers 
membranes from the ER, in close contact with the MOM, 
to the Golgi apparatus via specific transition vesicles), 
indicating the propensity of VDAC3 to be destroyed when 
heavily damaged (oxidized). 
In conclusion, we hypothesize that VDAC3 may not 
function only as a simple channel within the cell because 
of its high content of oxidation sensible cysteine residues, 
despite its general structure is possibly close to the other 
VDAC isoforms. Further studies will be needed to explore 
the particular role VDAC3 may have in redox signaling 
and response mechanisms to oxidative stress.
MAtErIALs AND MEtHODs
Cloning and mutagenesis
cDNAs for hVDAC1, hVDAC3 and hN1-VDAC3 
were cloned in pET21a vector (Novagen) with a 
C-terminal 6xHis-tag, as reported in [19, 21]. Mutagenesis 
was performed on hVDAC3 sequence by the QuickChange 
Site-Directed Mutagenesis kit (Stratagene). 
Specific couples of primers, designed to 
replace cysteine residues (C) with alanines (A), are 
reported as follow: C2A(5’-GGAGATATACATAT
GGCTAACACACCAACGTAC-3’,5’-GTACGTT
GGTGTGTTAGCCATATGTATATCTCC-3’); C8A 
ACACACCAACGTACGCTGACCTAGGAAAGGCT-
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3’,5’-AGCCTTTCCTAGGTCAGCGTACGTTGGTGT
GTT-3’); C122A(5’-TCCTATAAACGGGATGCTTTTA
GTGTTGGCAGT-3’,5’-ACTGCCAACACTAAAAGC
ATCCCGTTTATAGGA-3’). After confirming the single 
mutations by DNA sequencing, further PCR rounds were 
performed to create the double mutants hVDAC3 C2,8A, 
C2,122A, C8,122A, and the triple mutant hVDAC3 
C2,8,122A. cDNAs for hVDAC1, hVDAC3, hN1-VDAC3 
and hVDAC3 cys-mutants were also cloned in pYX212 
vector, as previously described [20]. All the constructs 
were confirmed by DNA sequencing.
Expression, purification and refolding of 6xHis-
tagged proteins
Escherichia coli BL21(DE3) cells were transformed 
with pET21a containing the native or mutagenized 
hVDAC genes. Proteins expression was performed by 
addition of 1 mM isopropyl-β-D-thiogalactopyranoside 
(IPTG, Sigma) at an optical density (λ = 595 nm) of ∼0.6 
at 37°C for 3 h, as reported in [21]. Bacterial cell were 
resuspended in buffer B (8 M urea, phosphate buffer, pH 
8.0) and shaked overnight at 4 °C. After pelleting cell 
debris by centrifugation, the clear lysate was loaded onto a 
Ni-NTA agarose (Qiagen) packed column pre-equilibrated 
with 10 column volumes of buffer B. The column was 
then washed twice with 5 volumes of buffer C (8 M urea, 
phosphate buffer, pH 6.2) and the purified proteins were 
eluted with 5 volumes of buffer E (8 M urea, phosphate 
buffer, pH 3.5). The denatured protein mixture was added 
drop-wise to a refolding buffer (25 mM Tris, 100 mM 
NaCl, 1 mM EDTA, 1% (v/v) lauryldimethylamine-oxide 
(LDAO, Sigma), pH 7.0) in order to obtain a ten-fold 
dilution of the urea concentration, and was gently stirred 
overnight at 4°C. The protein solution was dialyzed 
against 100 volumes of a dialysis buffer (25 mM Tris, 1 
mM EDTA, 0.1% LDAO, pH 7.0) with Thermo Scientific 
Slide-A-Lyzer Dialysis Cassettes (3.5 K MWCO) two 
times for 2 h and one time for 1 day at 4°C. All the steps 
of the refolding procedure were carried out without adding 
any reducing agent. The protein purity was verified by 
SDS-PAGE and Comassie staining. Purified samples were 
stored at -20°C.
Preparation of VDAC3 enriched fractions from 
rat liver mitochondria
Rat liver mitochondria were prepared by standard 
procedure [34]. 25 mg of rat liver mitochondria were 
solubilized for 20 min on ice with 5 ml of buffer A (3% 
Triton X-100, 10 mM TrisHCl, 1 mM EDTA pH 7.0) and 
then centrifuged at 17,400 x g for 30 min at 4 °C. The 
supernatant was loaded onto 5 g of dry hydroxyapatite 
(Bio-Gel HTP, Biorad) packed in a glass Econo-column 
2.5 X 30 cm (Biorad). The column was eluted at 4°C with 
3 ml of buffer A and five fraction of 0.6 ml were collected 
[34]. Samples were stored at -20°C. 
Electrophoretic analysis
Proteins electrophoretic techniques are reported in 
the Supplementary Materials.
Electrophysiological analysis
Refolded hVDAC3 wild type and mutants were 
reconstituted into a PLB (planar lipid bilayer) as described 
previously [19]. Bilayers of approx. 150-200 pF capacity 
were prepared using purified soybean asolectin. The 
standard experimental medium contained 1 M KCl, 10 
mM Hepes/pH 7.2 (set using KOH). Control experiments 
with empty membrane or with detergents used for the 
purification showed no activity. All voltages reported 
are those of the cis chamber, zero being assigned by 
convention to the trans (grounded) side. Currents are 
considered as positive when carried by cations flowing 
from the cis to the trans compartment. Data were acquired 
using a Bilayer Clamp amplifier (Warner Instruments, 
USA) at 100 µs/point, filtered at 300 Hz and analyzed 
offline using the pClamp program set (Axon Instruments, 
Union City, CA, USA). Histograms were fitted using 
Origin7.5 program set. Leak was not subtracted.
Yeast strains and viability spot assay
Wild type Saccharomyces cerevisiae strain BY4742 
[MAT a, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0] and isogenic 
porin-depleted mutant Δpor1 [MATa, his3Δ1, leu2Δ0, 
lys2Δ0, ura3Δ0, por1::kanMX4] were obtained from 
EUROSCARF (Frankfurt, Germany) as already reported 
[20]. Δpor1 strain was used for heterologous expression of 
native or mutant hVDACs; BY4742 was used as reference. 
Yeast strains were grown on rich medium YP (1% yeast 
extract, 2% peptone) supplemented with 2% glucose 
(YPD) or 2% glycerol (YPY) and minimal medium 
(0.67% yeast nitrogen base) containing 2% glucose (SD) 
or 2% glycerol (SY) supplemented with 10 μg/ml of the 
appropriate nutritional requirements according to the 
genotype of the strains. Agar (2%) was added for solid 
plates. For the viability spot assay, cell suspensions at 
the concentration of 108 cells/mL were transferred in 
microtiter plates, serially ten-fold diluted and spotted onto 
YPD and YPY plates. Incubation was performed at 28°C 
and 37°C for three-five days before recording. 
Mass spectrometry analysis
Mass spectrometry data were acquired on an 
Orbitrap Fusion Tribrid (Q-OT-qIT) mass spectrometer 
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(ThermoFisher Scientific, Bremen, Germany) equipped 
with a ThermoFisher Scientific Dionex UltiMate 3000 
RSLCnano system (Sunnyvale, CA). Full details are in 
the Supplementary Materials.
Thermal denaturation experiments
Wild type and mutants hVDAC3 cloned in pET21a 
were expressed as inclusion bodies in E. coli C41 cells. 
Protein purification was performed using reported 
methods [54]. Protein refolding was achieved by removing 
guanidine hydrochloride according to the protocol 
described previously for hVDAC2 [40]. The secondary 
structure content of refolded hVDAC3 was determined 
using far-UV circular dichroism (CD) spectropolarimetry 
on a Peltier-controlled JASCO J-815 instrument. Further 
details are presented in Supplementary Materials. 
Molecular dynamics simulations
The Molecular Dynamics simulations of the 
hVDAC3 channel with and without a disulfide bond in 
position 2-8 were run on a homology model built using 
the mouse VDAC1 as template as detailed in [26]. 
Technical description of the procedure is reported in the 
Supplementary Materials. 
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